Charité-Universitätsmedizin Berlin/Molekulares Krebsforschungszentrum der Charité-MKFZ, 13353 Berlin, Germany.
J Mol Med (Berl). 2011 Sep;89(9):869-75. doi: 10.1007/s00109-011-0770-2. Epub 2011 May 19.
Activated oncogenes evoke cellular fail-safe programs such as apoptosis, senescence, or autophagy to protect the organism from the expansion of damaged and potentially harmful cells. Non-cell-autonomous interactions between tumor cells and nonmalignant bystander cells add to cell-autonomous modes of tumor suppression during tumor development and progression. In particular, the role of stroma or host immune cells converting tumor-generated signals into a response that feeds back to the tumor cell population has been experimentally underappreciated. Using the Eμ-myc transgenic mouse lymphoma model, we elucidated how constitutive Myc signaling indirectly promotes cellular senescence via cytokines that were released by nonmalignant cells in response to oncogene-evoked cell-autonomous effects. Specifically, Myc primarily promotes apoptosis in a subset of the tumor cell population, leading to the attraction of macrophages, which subsequently engulf the apoptotic remainders. Phagocytosis-activated macrophages, in turn, exhibit strongly increased secretion of various cytokines, among them transforming growth factor beta to an extent that is capable of inducing cellular senescence in surrounding malignant cells. Our findings, recapitulated in human aggressive B-cell lymphomas, unveil that apoptosis and senescence are not simply two context-dependent cell-autonomous choices of stress responses, but rather cooperate via extracellular mediators-namely cells of the innate immune system-to profoundly limit tumorigenesis in vivo. A deeper mechanistic understanding of the organismic interconnection between different fail-safe programs will help to identify cellular components of the tumor stroma and their signal mediators that are readily available to impose a second line of host defense against cancer cells. This will open new perspectives for the development of antineoplastic therapies, whose targets not only encompass tumor but also stroma cell populations.
激活的癌基因会引发细胞故障安全程序,如细胞凋亡、衰老或自噬,以保护机体免受受损和潜在有害细胞的扩张。肿瘤细胞与非恶性旁观者细胞之间的非细胞自主相互作用增加了肿瘤发展和进展过程中细胞自主的肿瘤抑制模式。特别是,基质或宿主免疫细胞将肿瘤产生的信号转化为反馈给肿瘤细胞群体的反应的作用,在实验中被低估了。使用 Eμ-myc 转基因小鼠淋巴瘤模型,我们阐明了持续的 Myc 信号如何通过非恶性细胞在响应癌基因诱发的细胞自主效应时释放的细胞因子,间接促进细胞衰老。具体而言,Myc 主要在肿瘤细胞群体的一部分中促进细胞凋亡,导致巨噬细胞的吸引,巨噬细胞随后吞噬凋亡的剩余物。吞噬作用激活的巨噬细胞,反过来,强烈增加各种细胞因子的分泌,其中转化生长因子β的程度足以诱导周围恶性细胞发生细胞衰老。我们在人类侵袭性 B 细胞淋巴瘤中重现的发现表明,凋亡和衰老不仅仅是两种依赖于上下文的细胞自主应激反应的选择,而是通过细胞外介质——即先天免疫系统的细胞——合作,从而在体内深度限制肿瘤发生。对不同故障安全程序之间的机体相互联系的更深入机制理解将有助于鉴定肿瘤基质的细胞成分及其信号介质,这些成分可轻易地对癌细胞施加第二线宿主防御。这将为抗肿瘤治疗的发展开辟新的视角,其目标不仅包括肿瘤,还包括基质细胞群体。